INTRODUCTION:

Hydrogels are soft, water-absorbing materials made from three-dimensional networks of water loving (hydrophilic) polymers. They can take in a large amount of water or body fluids while still keeping their shape. Because they are soft, hold water well, and are safe for use in the body, hydrogels resemble natural tissues and are ideal for medical and drug delivery uses. Over the years, these materials have improved greatly from being simple carriers of drugs to advanced "smart" systems that can react to changes in the body or environment. One of the biggest challenges in drug delivery is making sure the drug reaches the exact place it’s needed and is released slowly over time, without causing side effects throughout the whole body. Traditional methods often fail at this, as drugs tend to spread everywhere or get cleared from the body too quickly¹.

To solve this issue, scientists have developed stimuli-responsive or "smart" hydrogels. These materials can change their structure or behavior when they sense certain conditions like changes in pH, temperature, enzymes, redox levels, magnetic fields, or even light. This ability allows for better control of when and where the drug is released. For example, in cancer treatment, pH-sensitive hydrogels can release medicine only in the acidic environment around a tumor. Similarly, enzyme-responsive hydrogels release drugs specifically where disease-related enzymes are present, such as in inflamed tissue. By designing hydrogels to respond in this way, it becomes possible to deliver treatments more accurately, with fewer side effects. This also supports the idea of personalized medicine, where treatment is tailored to each person’s unique condition. These smart hydrogels can carry many types of treatments, including small drug molecules, proteins, peptides, genetic materials, or even living cells. This review focuses on explaining how these smart hydrogels are designed, the types of triggers they respond to, and how they are used for targeted drug delivery. It also looks at the latest developments, current challenges, and what the future might hold for turning these smart systems into real medical treatments².

Structure and Chemistry of Hydrogels:

Hydrogels are soft, three-dimensional materials made from water attracting polymers. They can soak up and hold large amounts of water or body fluids without breaking down or dissolving. Their structure comes from a network of polymer chains that are linked together either by physical interactions or chemical bonds forming a gel like framework. This special design gives hydrogels both strength and flexibility, allowing them to stay stable while also remaining soft and similar in texture to natural body tissues.³

Structural Framework:

Figure 1: Structure of Hydrogel³

The basic structure of a hydrogel consists of:

· Polymer backbone: Responsible for the hydrogel’s overall properties, such as strength, elasticity, and hydrophilicity.

· Crosslinks: These are the points where polymer chains are interconnected. Crosslinking can be physical (reversible, non-covalent interactions) or chemical (irreversible, covalent bonding).

· Water phase: Occupies the space within the polymer network and acts as a medium for the transport of drugs, nutrients, or signaling molecules.

Unique structure of hydrogels can absorb a lot of water and swell without losing their shape or breaking apart. This makes them especially useful for medical purposes such as delivering drugs, healing wounds, and supporting tissue repair.

Chemical Composition and Interactions:

Hydrogels are made using either natural or man-made (synthetic) polymers that have special chemical groups like hydroxyl (-OH), carboxyl (-COOH), amide (-CONH₂), or sulfonic acid (-SO₃H). These groups help the hydrogel attract and hold water, and also allow it to interact with biological substances, such as drugs or proteins.⁴

The chemistry of hydrogel network governs:

· Swelling behavior: The ability of hydrogel to absorb water depends on polymer hydrophilicity and crosslink density.

· Stimuli-responsiveness: Functional groups in the hydrogel structure can respond to changes in pH, temperature, or other environmental cues, making them “smart” materials.

· Drug interaction: Ionic or hydrogen bonding between drug and the polymer network affects the drug release profile.

Natural vs. Synthetic Polymers Used in the Hydrogel Formation:

Choice of the polymer significantly influences the biocompatibility, degradability, and drug release behavior of the hydrogel system. Polymers can be derived from natural or synthetic sources, each with unique advantages and limitations.

Natural Polymers:

These biopolymers come from natural sources like plants, animals, or microbes. They are usually safe for the body (biocompatible) and can break down naturally over time (biodegradable).⁵

Examples:

Alginate: A polysaccharide from brown algae, gelled using divalent cations.

Chitosan: A cationic polysaccharide obtained from chitin, responsive to pH.

Gelatin: Derived from collagen, used for temperature-sensitive hydrogels.

Hyaluronic acid, cellulose, carrageenan, dextran – widely used in tissue-compatible drug delivery systems.

Limitations: Batch variability, limited mechanical strength, and susceptibility to microbial contamination.

Synthetic Polymers:

These are man made polymers known for their consistent quality and customizable properties. They are commonly used when strong structure, reliable results, and responsiveness to specific triggers are needed.

Examples include:

· Poly (N-isopropylacrylamide) (PNIPAAm): A polymer that responds to temperature changes.

· Poly (ethylene glycol) (PEG): Water-loving, biocompatible, and often blended with other materials.

· Polyvinyl alcohol (PVA), polyacrylic acid (PAA), and poly (lactic-co-glycolic acid) (PLGA): Often used for slow and controlled drug release.

Limitations:

May require chemical modification to improve biodegradability or reduce toxicity⁵

Classification of Stimuli-Responsive Hydrogels:

Stimuli-responsive hydrogels also called smart or intelligent hydrogels are advanced materials made from polymers that can change their structure or behavior when exposed to certain triggers. These changes might include swelling, turning from a liquid to a gel, or breaking down, and can be either reversible or permanent. The triggers can come from inside the body or be applied from outside. When activated, these hydrogels can release drugs in a controlled way or perform specific functions at the right place and time, making them excellent tools for targeted and time-controlled drug delivery.

These smart hydrogels are generally grouped into two main types based on what kind of stimulus activates them:

Internal Stimuli-Responsive Hydrogels:

These hydrogels can be designed to respond to physiological or pathological conditions within the body. Internal triggers are often related to the local microenvironment at the disease site, allowing for selective drug release at the target location.⁶

pH-Responsive:

pH-responsive hydrogels are designed to swell or shrink in response to variations in pH. These systems contain ionizable functional groups such as carboxyl or amino groups that become charged under specific pH conditions. In acidic environments (like the tumor microenvironment or stomach), protonation of basic groups can cause hydrogel swelling and trigger drug release. Similarly, in basic pH conditions (such as the intestine), deprotonation of acidic groups can lead to increased porosity and controlled release. These hydrogels are particularly valuable in targeting pH-variable sites in the gastrointestinal tract or tumor tissues, ensuring localized and efficient drug delivery.⁷

Temperature-Responsive:

Temperature-sensitive hydrogels respond to changes in ambient or body temperature by altering their physical state. They typically exhibit a critical temperature either lower (LCST) or upper (UCST) at which the polymer undergoes a sol gel or swelling transition.⁸ Hydrogels based on polymers like poly(N-isopropylacrylamide) (PNIPAAm) show phase separation around body temperature, allowing them to form gels in situ after injection. This property is highly beneficial for site-specific delivery of drugs, especially in minimally invasive formulations such as injectable implants or thermosensitive ocular systems.

Enzyme-Responsive:

These hydrogels are engineered to degrade or change their structure in response to specific enzymes that are overexpressed in diseased tissues. The hydrogel matrix includes peptide or polymer linkages that are cleavable by enzymes such as matrix metalloproteinases (MMPs), hyaluronidase, or trypsin. In pathological sites like tumors, inflamed tissues, or wounds, these enzymes are present at elevated levels and selectively trigger the breakdown of the hydrogel, releasing the encapsulated drug.⁹ This specificity enhances targeted therapy while minimizing effects on healthy tissue.

Redox-Responsive:

Redox-responsive hydrogels exploit the difference in redox potential between extracellular and intracellular environments, particularly in pathological conditions like cancer. These hydrogels often contain disulfide bonds that remain stable in extracellular fluid but are rapidly cleaved in the presence of high intracellular concentrations of reducing agents like glutathione (GSH).¹⁰ The cleavage leads to the degradation of the hydrogel matrix and subsequent drug release inside cells. This type of hydrogel is especially suitable for delivering anticancer drugs that require intracellular activation.

External Stimuli-Responsive Hydrogels:

These hydrogels respond to externally applied triggers, allowing precise control over drug release using non-invasive techniques.

Light-Responsive:

Light responsive hydrogels are specially designed materials that change their structure or behavior when exposed to certain types of light, such as ultraviolet (UV), visible, or near-infrared (NIR) light. These hydrogels are usually modified with light-sensitive components, like azobenzene or spiropyran, which react to light by changing shape or breaking apart. When activated by light, the hydrogel can swell, break down, or form tiny openings allowing for controlled and precise drug release exactly where and when it's needed. Because they can be triggered without surgery or physical contact, they are especially useful for treatments like skin applications or targeting tumors in specific areas.

Magnetic field-Responsive:

Magnetic hydrogels incorporate magnetic nanoparticles (e.g., Fe₃O₄) within their polymeric matrix, allowing them to respond to the external magnetic fields. When exposed to an alternating magnetic field, these particles generate heat or mechanical motion, causing the hydrogel to soften, swell, or release its drug content. The remote-controllability of these systems enables on-demand drug delivery with minimal invasiveness, making them promising for deep tissue therapies, targeted cancer treatment, and post-surgical implants.¹¹

Electric Field-Responsive:

These hydrogels are composed of the polymers that contain charged groups or are conductive in nature. Under an applied electric field, ionic movement within the network leads to swelling, shrinking, or structural rearrangement. This property allows controlled release of drugs in an electrically modulated manner.¹² Electric-responsive hydrogels can be explored for implantable drug delivery devices, particularly in neurological or cardiovascular systems where localized electrical stimulation is feasible.

Ultrasound-Responsive:

Ultrasound-sensitive hydrogels are triggered by acoustic waves that generate mechanical stress or cavitation within the gel matrix. These effects can cause temporary structural disruption, enhancing permeability or inducing drug release. Focused ultrasound allows precise targeting of the hydrogel, making it an ideal tool for non-invasive delivery to internal organs or tumors. Ultrasound-responsive systems combine safety, controllability, and spatial precision, making them attractive candidates for advanced therapeutic applications.

Table 1: Classification of Stimuli Responsive Hydrogels

Stimulus type	Sub type	Mechanism	Applications
Internal	pH responsive	Ionization of functional groups	Tumor, GI tract
	Temperature responsive	Sol-Gel transformation at critical temperature	Injectable depots, eyes
	Enzyme responsive	Enzymatic cleavage of polymer linkers	Cancer, Inflammation
	Redox responsive	Disulfide bond cleavage via glutathione	Intracellular delivery
External	Light responsive	Photo ionization or cleavage	Topical ocular therapy
	Magnetic responsive	Heat or motion via magnetic field	Deep tissue targeting
	Electric responsive	Swelling via electrical potential	Neural, controlled patches
	Ultrasound responsive	Acoustic cavitation and matrix disruption	Non invasive delivery

Design Considerations for Pharmacological Targeting:

The design of stimuli responsive hydrogels for pharmacological targeting requires careful consideration of multiple interdependent factors that influence the therapeutic efficiency, safety, and precision of drug delivery. These hydrogels must be tailored not only to respond to the specific physiological or external stimuli but also to meet the requirements of the target disease, site of administration, and drug properties.

Drug Loading Efficiency and Release Kinetics:

An ideal hydrogel must be capable of incorporating therapeutic agents without compromising their stability or activity. The method of drug loading whether by entrapment, adsorption, or covalent attachment should be chosen based on the drug’s physicochemical characteristics. Furthermore, the release rate must align with the therapeutic window of the drug. For stimuli-responsive systems, the response should be sharp and predictable upon encountering the intended stimulus, enabling rapid and targeted drug release while minimizing premature leakage.¹⁴

Stimulus Selection and Responsiveness:

The choice of stimulus pH, temperature, enzymes, redox potential, light, magnetic fields, or electric fields depends on the target site’s physiological conditions. For example, tumor tissues often have an acidic pH and overexpress certain enzymes, while inflamed regions may show elevated redox potential. The responsiveness of the hydrogel should be fine-tuned to match the intensity and duration of the target stimulus to ensure precise activation and avoid unintended release in non targeted tissues.

Site-Specific Targeting:

Stimuli-responsive hydrogels should be designed to respond selectively at the disease site. This involves understanding the local microenvironment of the target tissue and engineering the hydrogel accordingly.¹⁵ For instance, enzyme-responsive hydrogels can be tailored to degrade only in the presence of matrix metalloproteinases overexpressed in tumor tissues. Moreover, combining targeting ligands (e.g., folate, antibodies) with hydrogels can further enhance specificity toward certain cell types or receptors.

Biocompatibility and Safety:

Biocompatibility is critical for any drug delivery system, especially those designed for implantation or injection. The hydrogel should not provoke an immune response, inflammation, or toxicity. The materials use whether synthetic or natural must be non-immunogenic and non-toxic. Additionally, degradation byproducts must be harmless and easily eliminated from the body to avoid accumulation or interference with normal physiology.

Mechanical Properties and Injectability:

The hydrogel must possess adequate mechanical strength to maintain integrity at the application site, especially for load-bearing tissues or implants. Simultaneously, it should be soft and flexible enough to mimic biological tissues and allow comfortable administration. Injectable hydrogels should exhibit shear-thinning behavior or in situ gelation for minimally invasive delivery and conform to irregularly shaped target areas.¹⁶

Stability and Storage Conditions:

For practical use, hydrogels must remain stable during storage and retain their responsiveness over time. Stability is influenced by polymer composition, crosslinking density, moisture content, and potential degradation during transportation. Formulations should be resistant to temperature fluctuations and microbial contamination, especially if designed for long-term storage or commercial use.

Scalability and Manufacturing Feasibility:

While laboratory-scale synthesis allows flexibility, hydrogels intended for clinical translation must be easy to manufacture consistently and economically. The fabrication process should comply with good manufacturing practices (GMP), be reproducible, and enable uniform drug distribution within the matrix. Avoiding toxic reagents or complicated synthesis steps enhances clinical feasibility.

Applications in Pharmacological Targeting:

Stimuli-responsive hydrogels hold great promise for improving drug delivery by releasing medication directly at the disease site, only when triggered by specific internal or external signals. Their ability to respond to changes in the environment in real time makes them especially useful in medical treatments particularly for complex or long-term conditions. By delivering drugs in a more targeted way, these smart hydrogels can help reduce side effects and increase the overall effectiveness of the therapy.

Cancer Therapy:

Cancer is one of the toughest diseases to treat because tumors can vary widely, become resistant to drugs, and chemotherapy often causes harmful side effects throughout the body. Stimuli-responsive hydrogels help overcome these challenges by allowing drugs to be released slowly, directly at the tumor site, and only when triggered. For example, pH-responsive hydrogels can release cancer drugs in the acidic environment around tumors, while enzyme-sensitive hydrogels break down in response to enzymes found in cancerous tissues. Redox-sensitive hydrogels can release medicine inside cancer cells by reacting to high levels of glutathione, a substance commonly found in those cells. Some newer hydrogels are designed to respond to multiple triggers like pH, enzymes, and redox changes making them even more precise. These multi-responsive systems are also being explored for delivering both chemotherapy drugs and gene therapies together.¹⁷

Inflammatory Diseases:

Inflammatory diseases like rheumatoid arthritis, colitis, and chronic wounds are often linked to specific triggers such as certain enzymes, acidic pH, or oxidative stress. Hydrogels that respond to these signals can release drugs directly at the inflamed site, helping reduce side effects and unnecessary exposure to the rest of the body¹⁸. For instance, enzyme-sensitive hydrogels break down in the presence of inflammation-related enzymes and release anti-inflammatory drugs only where they're needed. Similarly, redox-responsive hydrogels can release antioxidants in areas under oxidative stress to help restore balance. These smart systems are designed to deliver medicine when needed, matching the changing patterns of inflammation.

Neurological Disorders:

Treating neurological disorders is especially difficult because of the blood-brain barrier (BBB), which blocks many drugs from reaching the brain. Stimuli-responsive hydrogels offer a new way to deliver treatments that can either bypass or cross the BBB. For instance, temperature-sensitive (thermoresponsive) hydrogels can be injected directly into the spinal area or brain, where they form a gel that slowly releases drugs like neuroprotective agents or anti-seizure medications. Other smart hydrogels, which respond to changes in pH or specific enzymes, can be designed to release medicine during brain inflammation or reduced blood flow common in conditions like Alzheimer’s, Parkinson’s, or stroke.¹⁹

Ophthalmic and Transdermal Drug Delivery:

Hydrogels are particularly suitable for ocular and skin applications due to their biocompatibility, moisture-retaining ability, and non-invasive administration. In ophthalmology, temperature- and light-responsive hydrogels have been developed to improve the residence time of drugs in the eye and reduce dosing frequency.²⁰ For transdermal delivery, hydrogels sensitive to external stimuli such as heat or ultrasound can enhance skin permeability and deliver drugs on demand. These systems are being applied for conditions such as glaucoma, bacterial conjunctivitis, psoriasis, and hormone replacement therapy.

Injectable and Implantable Systems:

Stimuli-responsive hydrogels are ideal for injectable or implantable drug depots that provide long-term, localized therapy. Injectable hydrogels, particularly those responsive to temperature, can be delivered as liquids that gel at body temperature, forming drug-releasing reservoirs at the site of injection. Implantable hydrogels, on the other hand, can be designed to degrade slowly or in response to specific internal stimuli, ensuring sustained drug release over weeks or months. Such systems are being used in post-surgical cancer therapy, orthopedic treatments, and contraception.

Recent Advances and Innovations:

The field of stimuli-responsive hydrogels is evolving rapidly, driven by advances in polymer science, nanotechnology, and biomedical engineering. Recent innovations focus on enhancing the specificity, responsiveness, and multifunctionality of hydrogels to meet the complex demands of modern pharmacological therapies. These developments are expanding the scope of hydrogel applications and paving the way toward clinically viable, next-generation smart drug delivery platforms.

Multi-Stimuli-Responsive Hydrogels

Figure 2: Multi-Stimuli-Responsive Hydrogels ²¹

One of the most significant breakthroughs is the development of hydrogels that respond to multiple stimuli simultaneously such as pH, temperature, and redox conditions. These systems offer superior control over drug release, especially in complex disease environments like tumors, where multiple abnormal signals coexist. For example, a hydrogel that responds to both acidic pH and elevated glutathione can selectively deliver anticancer drugs within the intracellular compartments of tumor cells, minimizing impact on healthy tissues. This combinatorial approach enhances targeting specificity and reduces the risk of premature drug leakage²¹.

Nanocomposite and Hybrid Hydrogels:

Integrating nanoparticles or nanostructures into hydrogel networks has given rise to hybrid or nanocomposite hydrogels with enhanced mechanical, thermal, and responsive properties. Nanoparticles such as magnetic iron oxide, gold nano-shells, graphene oxide, or mesoporous silica are embedded within the hydrogel to introduce responsiveness to external triggers like magnetic fields, light, or ultrasound. Additionally, these nanomaterials can act as carriers for hydrophobic drugs or imaging agents, enabling theranostic applications (therapy + diagnostics) in personalized medicine.²²

3D and 4D Printed Hydrogels:

The incorporation of 3D printing technologies has enabled precise control over the shape, structure, and drug distribution within hydrogel constructs. 3D-printed hydrogels are especially useful for patient-specific implants or scaffolds in tissue engineering. A more advanced concept 4D printing adds the dimension of time by using stimuli-responsive materials that change shape or function after implantation in response to environmental changes. This innovation holds promise for developing smart implants that adapt dynamically to physiological changes.²³

Injectable Self-Healing Hydrogels

Figure 3: Injectable Self-Healing Hydrogels ²⁴

Injectable hydrogels that exhibit self-healing properties have garnered attention for their ability to recover their structure after mechanical stress, such as compression or injection through a fine needle. These hydrogels often rely on reversible covalent bonding (e.g., Schiff base reactions, disulfide bonds) or dynamic physical interactions (e.g., host-guest chemistry). Their self-healing ability improves mechanical resilience and prolongs the functional life of the hydrogel, making them highly attractive for drug depots in musculoskeletal, ocular, or dermal applications.

Hydrogel–Sensor Integration for Feedback-Controlled Drug Delivery:

An emerging frontier involves integrating biosensors with hydrogels to create closed-loop drug delivery systems. These systems continuously monitor physiological signals such as glucose levels, pH, or inflammatory markers and trigger drug release accordingly. For example, a glucose-responsive hydrogel can release insulin only when blood glucose levels rise beyond a certain threshold. This level of automation and real-time control has the potential to revolutionize chronic disease management, particularly in diabetes and metabolic disorders.

Biodegradable and Environmentally Friendly Hydrogels:

With increasing emphasis on sustainability and safety, researchers are developing hydrogels made from renewable, biodegradable, and non-toxic materials. Natural polymers like silk fibroin, gelatin, and cellulose are being modified to create smart, responsive networks that degrade into harmless byproducts after drug delivery.²⁵ These eco-friendly systems are particularly beneficial for temporary implants or topical applications, where long-term presence of synthetic polymers may be undesirable.

Challenges and Limitations:

Despite the significant progress in the development of stimuli-responsive hydrogels, several challenges still limit their widespread clinical application. Translating these sophisticated systems from research laboratories to real-world therapeutic settings requires overcoming barriers related to safety, performance, reproducibility, and regulatory compliance.

Reproducibility and Scalability:

A major challenge in the production of stimuli-responsive hydrogels lies in ensuring batch-to-batch consistency and scalability. Many advanced hydrogels are synthesized using complex chemical processes that are difficult to reproduce on a large scale without compromising performance. Variability in polymer quality, crosslinking efficiency, and environmental responsiveness can lead to inconsistent drug release profiles, posing a major obstacle for industrial-scale manufacturing.

Limited Stimulus Sensitivity in Vivo:

While hydrogels show excellent responsiveness to stimuli under controlled laboratory conditions, their behavior may not be as predictable within the human body. The intensity of stimuli such as pH or temperature variations may be too subtle to induce a sufficient response. For example, the difference in pH between healthy tissue and tumor sites may be too small to activate pH-responsive hydrogels effectively. Additionally, external stimuli like light or ultrasound may not penetrate deep enough to trigger the hydrogel, especially in internal organs.

Biocompatibility and Long-Term Safety:

Although many hydrogels are made from biocompatible materials, the inclusion of synthetic polymers, nanoparticles, or chemical crosslinkers may raise toxicity concerns. Incomplete degradation or accumulation of hydrogel components in tissues can provoke immune responses or interfere with normal physiological functions. Furthermore, the degradation products of certain synthetic hydrogels may be cytotoxic or inflammatory, limiting their use in sensitive applications like the central nervous system or pediatric care.

Complex Formulation and High Cost:

The formulation of multi-responsive hydrogels often involves multiple steps, precise conditions, and high-purity reagents, making the process expensive and time-consuming. Additionally, the incorporation of targeting ligands, sensors, or nanomaterials increases the formulation complexity and cost. These factors may limit the commercial viability of such systems, particularly for low-resource settings or non-life-threatening conditions.

Stability and Shelf Life:

Some stimuli-responsive hydrogels exhibit poor physical or chemical stability under storage conditions. They may lose their responsiveness, undergo premature degradation, or experience changes in swelling capacity, affecting their therapeutic performance. Moisture sensitivity, microbial contamination, and temperature fluctuations during storage and transport can further compromise the shelf life of these formulations.

Future Perspectives:

Stimuli-responsive hydrogels represent a frontier in smart drug delivery systems, offering precise, site-specific, and controlled therapeutic outcomes. As scientific understanding of disease microenvironments deepens and material science advances, the future of these intelligent hydrogels holds great promise—not just in improving pharmacological efficacy but also in enabling personalized, adaptive, and even self-regulating treatments.

Integration with Biosensing and Feedback-Controlled Systems:

Future hydrogel systems are likely to integrate biosensors capable of real-time monitoring of biomarkers such as glucose, pH, lactate, or cytokines. This would allow the hydrogel to operate in a closed-loop system—where the drug is released only in response to a detected physiological change. Such feedback-responsive systems can revolutionize chronic disease management (e.g., diabetes, epilepsy) by reducing the need for constant medical supervision and enabling self-adjusting therapy.²⁶

Personalized and Precision Medicine:

Advancements in genomics and molecular diagnostics are paving the way for patient-specific therapies. Stimuli-responsive hydrogels could be customized based on an individual’s genetic profile, disease progression, or biomarker expression. By tailoring responsiveness to unique pathological conditions, these systems could deliver drugs at the right dose, time, and location for each patient, thereby minimizing side effects and maximizing therapeutic impact.²⁷

4D and Shape-Morphing Hydrogels:

Building on the concept of 3D printing, the next generation of smart hydrogels will involve 4D constructs—materials that change their shape or function over time in response to stimuli. These hydrogels could be programmed to unfold, expand, or degrade in complex patterns, making them suitable for dynamic implants, self-deploying medical devices, or organ-specific conformations. This advancement could significantly enhance tissue engineering and post-surgical drug delivery applications.²⁸

Bioinspired and Self-Healing Systems:

Mimicking natural tissues and self-healing mechanisms is a growing trend in biomaterials research. Future hydrogels are expected to incorporate reversible bonds or dynamic crosslinking strategies that allow them to repair mechanical damage autonomously. These properties will improve the durability of hydrogels in long-term therapeutic applications, particularly in mechanically active environments like joints, skin, or the gastrointestinal tract.²⁹

Expanded Use in Regenerative Medicine and Cell Therapy:

Stimuli-responsive hydrogels will play a critical role in delivering stem cells, growth factors, or genetic material in regenerative therapies. By protecting delicate biological agents and releasing them in response to injury-related signals, these hydrogels can support the repair and regeneration of damaged tissues. This application is particularly promising in wound healing, neural regeneration, and bone reconstruction.³⁰

Environmentally Conscious and Biodegradable Platforms:

As sustainability becomes a global concern, future hydrogel systems will increasingly rely on biodegradable, renewable, and non-toxic materials. Green chemistry approaches and plant-based polymers will be emphasized to develop eco-friendly hydrogel platforms that align with environmental safety and regulatory expectations³¹.

CONCLUSION:

Stimuli-responsive hydrogels represent a major advancement in modern drug delivery, offering precise control over how and when medications are released in response to specific internal or external signals. This smart behavior helps overcome many of the limitations seen in traditional delivery methods, such as poor targeting, rapid drug clearance, and unwanted side effects. With their adaptable designs, these hydrogels can be tailored to treat a wide range of health conditions, including cancer, inflammatory disorders, neurological diseases, and tissue injuries. Recent developments like multi-responsive hydrogels, those containing nanoparticles, self healing systems, and 3D/4D printed structures have greatly expanded their potential. Some systems even incorporate biosensors to allow personalized and responsive treatment. However, several hurdles remain, such as ensuring these materials perform well inside the body, can be manufactured on a large scale, and meet safety and regulatory standards. To bring these smart materials into widespread clinical use, collaboration among researchers, healthcare professionals, and regulatory experts will be essential.

REFERENCES:

1. Kasiński A, Zielińska-Pisklak M, Oledzka E, Sobczak M. Smart hydrogels–synthetic stimuli-responsive antitumor drug release systems. International Journal of Nanomedicine. 2020 Jun 25:4541-72.

2. Wells CM, Harris M, Choi L, Murali VP, Guerra FD, Jennings JA. Stimuli-responsive drug release from smart polymers. Journal of Functional Biomaterials. 2019 Jul 31;10(3):34.

3. Jayesh S. Gharat, Yogita V. Dalvi. Compressive Review on Hydrogel. Asian J. Pharm. Tech. 2018; 8 (3):172-181.

4. Earle Radha Rani, M. Ramadevi, Ayalasomayajula Lakshmi Usha. An Overview on Hydrophilic Three-Dimensional Networks: Hydrogels. Asian J. Pharm. Res. 2021; 11(1):23-28.

5. Yash Bhusari, Anuradha Khopade, Deep Morkhade, Vedant Junghare, Vishlesha Arokar. Formulation and Analysis of Tintiri Mucilage Based Sustained Release Hydrogel Beads for Hydroxyzine HCl. Asian Journal of Pharmaceutical Research. 2025; 15(2):127-3.

6. Chatterjee S, Hui PC. Stimuli-responsive hydrogels: An interdisciplinary overview. Hydrogels—smart materials for biomedical applications. 2018 Nov 5:1-23.

7. Rizwan M, Yahya R, Hassan A, Yar M, Azzahari AD, Selvanathan V, Sonsudin F, Abouloula CN. pH sensitive hydrogels in drug delivery: Brief history, properties, swelling, and release mechanism, material selection and applications. Polymers. 2017 Apr 12; 9(4):137.

8. Taylor MJ, Tomlins P, Sahota TS. Thermoresponsive gels. Gels. 2017 Jan 10; 3(1): 4.

9. Tauro JR, Gemeinhart RA. Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjugate Chemistry. 2005 Sep 21;16(5):1133-9.

10. Phillips DJ, Gibson MI. Redox-sensitive materials for drug delivery: targeting the correct intracellular environment, tuning release rates, and appropriate predictive systems. Antioxidants & Redox Signaling. 2014 Aug 10; 21(5): 786-803.

11. Li Z, Li Y, Chen C, Cheng Y. Magnetic-responsive hydrogels: From strategic design to biomedical applications. Journal of Controlled Release. 2021 Jul 10; 335: 541-56.

12. Browe DM, Thompson BC. Conducting polymer hydrogels for electrically responsive drug delivery. J Control Release. 2020 Dec 10; 328: 192–209

13. Zhou Y, Liu G, Guo S. Advances in ultrasound-responsive hydrogels for biomedical applications. Journal of Materials Chemistry B. 2022; 10(21): 3947-58.

14. Op't Veld RC, Walboomers XF, Jansen JA, Wagener FA. Design considerations for hydrogel wound dressings: strategic and molecular advances. Tissue Engineering Part B: Reviews. 2020 Jun 1; 26(3): 230-48.

15. Prasad Deshmukh, Mukund Tawar, Vaishnavi Chandak, Rachana Hallale, Alisha Hirani, Omkar Rajurkar. Preparation and Evaluation of Hydrogel Alginate Beads of Rifaximin. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(4): 285-0.

16. Amuge Vilas, S.S. Siddheshwar. A Review on Floating Microsphere. Asian Journal of Pharmacy and Technology. Tech. 2024; 14(1): 31-5.

17. Neha Deshmukh. Preparation and Evaluation of Sustained Release Hydrogel Alginate Beads of Meclizine Hydrochloride. Asian Journal of Pharmacy and Technology. 2022; 12(3): 202-6.

18. Kim YE, Kim J. ROS-scavenging therapeutic hydrogels for modulation of the inflammatory response. ACS Applied Materials and Interfaces. 2021 Dec 28; 14(20): 23002-21.

19. Ajwad N, Mustapha M, Idris Z, Lee SY. The Recent Applications of Stem Cell-Derived Exosomes and Hydrogels in Neurological Disorders. Tissue Engineering Part B: Reviews. 2025 May 5.

20. Fang G, Yang X, Wang Q, Zhang A, Tang B. Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases. Materials Science and Engineering: C. 2021 Aug 1; 127:112212.

21. Vamakshi Thaker, Praveen Tahilani. Formulation and Charaterization of Antifungal Drug Microemulsion Hydrogel for Topical Drug Delivery. Asian Journal of Pharmacy and Technology. 2022; 12(2):101-8.

22. Abhishek Kanugo, Aparajita Chakravarti. Recent Advances in the Biomedical Applications of Hydrogels. Asian Journal of Pharmacy and Technology. 2025; 15(3):289-5.

23. Parikshit Pise. A Review on Nanoparticle-Loaded Hydrogels for Extended Drug Release. Asian Journal of Pharmacy and Technology. Tech. 2024; 14(1):55-8.

24. Bertsch P, Diba M, Mooney DJ, Leeuwenburgh SC. Self-healing injectable hydrogels for tissue regeneration. Chemical Reviews. 2022 Aug 5; 123(2): 834-73.

25. Sannino A, Demitri C, Madaghiele M. Biodegradable cellulose-based hydrogels: design and applications. Materials. 2009 Apr 16; 2(2): 353-73.

26. Zhang G, Chen Y, Zhou W, Chen C, Liu Y. Bioenergy‐Based Closed‐Loop Medical Systems for the Integration of Treatment, Monitoring, and Feedback. Small Science. 2023 Oct; 3(10): 2300043.

27. Lan YX, De Yan J, Su HL, Wu CC, Kuo CH, Chiu CC, Chang MW, Takemoto L, Wu CC, Wang HM. Exploring the potential of dual-sensitive hydrogels for personalized precision medicine applications. Journal of the Taiwan Institute of Chemical Engineers. 2024 Oct 1; 163:105303.

28. Kirillova A, Maxson R, Stoychev G, Gomillion CT, Ionov L. 4D biofabrication using shape‐morphing hydrogels. Advanced Materials. 2017 Dec; 29(46): 1703443.

29. Liu Y, Wang J, Chen H, Cheng D. Environmentally friendly hydrogel: A review of classification, preparation and application in agriculture. Science of the Total Environment. 2022 Nov 10; 846:157303.

30. Shubham Tripathi, Somnath Patel, Ritesh Patel, Shraddha, Pushpendra, Sachin, Neetish, Mahendra, Kuldeep, Prashant, Rajesh Patel, Girish, Nitin, Tomanlal, Amrita Thakur, Mukta Agrawal, Ajazuddin, D. K. Tripathi, Amit Alexander. A Review on Biocompatible Hydrogel: Formulation Aspect and Evaluation. Res. J. Pharma. Dosage Forms and Tech. 2018; 10(2): 119-122.

31. Selvaraj S, Chauhan A, Dutta V, Verma R, Rao SK, Radhakrishnan A, Ghotekar S. A state-of-the-art review on plant-derived cellulose-based green hydrogels and their multifunctional role in advanced biomedical applications. International Journal of Biological Macromolecules. 2024 Mar 22:130991.

Received on 30.09.2025 Revised on 24.11.2025

Accepted on 26.12.2025 Published on 02.07.2026

Available online from July 15, 2026

Asian J. Res. Pharm. Sci. 2026; 16(3):278-286.

DOI: 10.52711/2231-5659.2026.00041

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.